J Gynecol Oncol.
2020 Nov;31(6):e92. 10.3802/jgo.2020.31.e92.
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups
- Bogani G
1 - Apolone G1
- Ditto A1
- Scambia G2
- Panici PB3
- Angioli R4
- Pignata S5
- Greggi S5
- Scollo P6
- Delia M1
- Franchi M7
- Martinelli F1
- Signorelli M1
- Lopez S1
- Donato VD3
- Valabrega G8,9
- Ferrandina G2
- Palaia I3
- Bergamini A10
- Bocciolone L10
- Savarese A11
- Ghezzi F12
- Casarin J12
- Pinelli C12
- Trojano V13
- Chiantera V14
- Giorda G15
- Sopracordevole F15
- Malzoni M16
- Salerno G17
- Sartori E18
- Testa A2
- Zannoni G2
- Zullo F19
- Vizza E20
- Trojano G21
- Chiantera A22
- Raspagliesi F1
- Affiliations
-
- 1Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
- 2UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy
- 3Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy
- 4Department of Gynecology, Università Campus Bio-Medico, Rome, Italy
- 5Urogynaecological Medical Oncology Unit Istituto Nazionale Tumori, IRCCS, Naples, Italy
- 6Department of Gynecology, Cannizzaro Hospital, Catania, Italy
- 7Department of Obstetrics and Gynaecology, AOUI Verona, University of Verona, Verona, Italy
- 8Candiolo Cancer Institute, FPO, IRCCS, Candiolo, Italy
- 9Department of Oncology, University of Torino, Torino, Italy
- 10Obstetrics and Gynecology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
- 11Oncologia Medica 1, IRCCS Istituto Nazionale Tumori Regina Elena, Roma, Italy
- 12Department of Obstetrics and Gynecology, University of Insubria, Varese, Italy
- 13Department of Obstetrics and Gynaecology, Mater Dei Hospital, Bari, Italy
- 14Department of Gynecologic Oncology, University of Palermo, Palermo, Italy
- 15Gynaecological Oncology Unit, Centro di Riferimento Oncologico (CRO) di Aviano, IRCCS, Aviano, Italy
- 16Endoscopica Malzoni, Center for Advanced Endoscopic Gynecological Surgery, Avellino, Italy
- 17Department of Gynecology, San Camillo-Forlanini Hospital, Rome, Italy
- 18Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
- 19Gynecology and Obstetrics Unit, Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy
- 20Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- 21Department of Obstetrics and Gynecology, University Medical School "A. Moro", Bari, Italy
- 22President of the Scientific Society, Italian Society of Gynecology and Obstetrics (SIGO), Bologna, Italy
- KMID: 2512057
- DOI: http://doi.org/10.3802/jgo.2020.31.e92
Abstract
Objective
Coronavirus disease 2019 (COVID-19) has caused rapid and drastic changes in cancer management. The Italian Society of Gynecology and Obstetrics (SIGO), and the Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies (MITO) promoted a national survey aiming to evaluate the impact of COVID-19 on clinical activity of gynecologist oncologists and to assess the implementation of containment measures against COVID-19 diffusion.
Methods
The survey consisted of a self-administered, anonymous, online questionnaire. The survey was sent via email to all the members of the SIGO, and MITO groups on April 7, 2020, and was closed on April 20, 2020.
Results
Overall, 604 participants completed the questionnaire with a response-rate of 70%. The results of this survey suggest that gynecologic oncology units had set a proactive approach to COVID-19 outbreak. Triage methods were adopted in order to minimize in-hospital diffusion of COVID-19. Only 38% of gynecologic surgeons were concerned about COVID-19 outbreak. Although 73% of the participants stated that COVID-19 has not significantly modified their everyday practice, 21% declared a decrease of the use of laparoscopy in favor of open surgery (19%). However, less than 50% of surgeons adopted specific protection against COVID-19. Additionally, responders suggested to delay cancer treatment (10%–15%), and to perform less radical surgical procedures (20%–25%) during COVID-19 pandemic.
Conclusions
National guidelines should be implemented to further promote the safety of patients and health care providers. International cooperation is of paramount importance, as heavily affected nations can serve as an example to find out ways to safely preserve clinical activity during the COVID-19 outbreak.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups
- Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
- Neurointervention in the Era of COVID-19: Korean Nationwide Survey, Literature Review, and Recommendations
- Recommendations for gynecologic cancer care during the COVID-19 pandemic
- Surviving the COVID-19 pandemic: early response of a gynecologic oncology unit in Singapore
